These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16901180)

  • 1. Single-day therapy for recurrent genital herpes.
    Tyring S; Berger T; Yen-Moore A; Tharp M; Hamed K
    Am J Clin Dermatol; 2006; 7(4):209-11. PubMed ID: 16901180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-day famciclovir therapy for recurrent genital herpes.
    Whitley R; Diaz-Mitoma F; Hamed K
    Curr Med Res Opin; 2006 Jul; 22(7):1307-10. PubMed ID: 16834829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes.
    Tyring S; Richwald G; Hamed K
    Arch Gynecol Obstet; 2007 Jan; 275(1):1-3. PubMed ID: 16957911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
    Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
    Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study.
    Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J;
    Sex Health; 2008 Sep; 5(3):219-25. PubMed ID: 18771636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.
    Bodsworth N; Fife K; Koltun W; Tyring S; Abudalu M; Prichard M; Hamed K
    Curr Med Res Opin; 2009 Feb; 25(2):483-7. PubMed ID: 19192993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of famciclovir in the management of genital herpes.
    Faro S
    Infect Dis Obstet Gynecol; 1998; 6(1):38-43. PubMed ID: 9678146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
    Sacks SL
    J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose famciclovir for the treatment of herpes labialis.
    Hull C; Spruance S; Tyring S; Hamed K
    Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital herpes simplex virus and its treatment: focus on famciclovir.
    Sacks SL
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):32-6. PubMed ID: 8840414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infections.
    Tyring S
    Skin Therapy Lett; 2001 Nov; 6(12):1-2, 5. PubMed ID: 11753535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.
    Vinh DC; Aoki FY
    Expert Opin Pharmacother; 2006 Nov; 7(16):2271-86. PubMed ID: 17059383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.